Question 1

What is Breyna?

Accepted Answer

Breyna is a combination medication that contains budesonide and formoterol fumarate dihydrate. Budesonide is a corticosteroid that helps reduce inflammation, while formoterol is a long-acting beta2-adrenergic agonist that works by relaxing the muscles in the airways.

Together, these two components help manage and prevent symptoms associated with chronic respiratory conditions. By combining an anti-inflammatory agent with a bronchodilator, the medication addresses both airway swelling and muscle constriction.

Question 2

What is Breyna used for?

Accepted Answer

Breyna is used to treat asthma and chronic obstructive pulmonary disease .

Question 3

How does Breyna work?

Accepted Answer

Mechanism of Action

Breyna is a combination inhaler that uses two different types of medication to manage respiratory conditions like asthma and chronic obstructive pulmonary disease (COPD).

Reducing Inflammation

One component, budesonide, is a corticosteroid. It works by reducing and preventing inflammation within the lungs. By decreasing the swelling and irritation in the lining of the airways, it helps prevent symptoms such as wheezing and coughing over time.

Opening the Airways

The second component, formoterol, is a long-acting beta2-adrenergic agonist (LABA). It acts as a bronchodilator by relaxing the smooth muscles that surround the bronchial tubes in the lungs. This relaxation allows the airways to stay open for a longer period, which improves airflow and makes breathing less difficult.

Combined Effect

While the bronchodilator provides relaxation of the muscles, the corticosteroid works to treat the underlying inflammation. Together, these medications provide both maintenance of open airways and long-term control of airway sensitivity to help prevent flare-ups.

Question 4

What are the active ingredients in Breyna?

Accepted Answer

The active ingredients in Breyna are budesonide and formoterol .

Question 5

What are the side effects of Breyna?

Accepted Answer

Common side effects of Breyna may include:

headache

upper respiratory infection

oral thrush

and others

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Breyna?

Accepted Answer

Breyna belongs to the retinoid drug class.

Question 7

What is the dosage of Breyna and how do I take it?

Accepted Answer

Breyna is administered by oral inhalation using a metered-dose inhaler. It should be used every day at the same times, typically once in the morning and once in the evening, even if you do not have active symptoms. This medication is intended for long-term maintenance and should not be used to treat a sudden asthma attack or breathing emergency.

Administration Steps

Shake the inhaler well for at least five seconds before each puff.

If the inhaler is new or has not been used for more than one week, it must be primed according to the manufacturer's instructions before use.

After inhaling the medication, rinse your mouth with water and spit it out. Do not swallow the water. This helps reduce the risk of developing a fungal infection in the mouth or throat.

Missed Dose

If you miss a dose, take it as soon as you remember. If it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not use extra medication to make up for a missed dose.

Question 8

Is Breyna safe during pregnancy and breastfeeding?

Accepted Answer

There are no adequate and well-controlled clinical studies of Breyna in pregnant women. However, maintaining control of asthma during pregnancy is important, as poorly controlled asthma can increase the risk of complications such as preeclampsia, low birth weight, and preterm delivery.

The two active ingredients in Breyna have different levels of available data:

Budesonide: Extensive data from observational studies and many years of use suggest that inhaled budesonide does not increase the risk of major birth defects when used during pregnancy.

Formoterol: There is limited information regarding the use of formoterol in pregnant women. In animal studies, very high doses of formoterol were associated with developmental issues.

Because formoterol is a beta-agonist, it may potentially interfere with uterine contractions during labor. Its use during labor and delivery should be discussed with a healthcare provider.

Budesonide is known to pass into human breast milk in small amounts. It is not currently known if formoterol passes into human breast milk, although it has been detected in the milk of animal subjects. Decisions regarding the use of Breyna while breastfeeding should involve a discussion with a healthcare professional to weigh the benefits of treatment for the mother against the potential risks to the infant.

Question 9

What forms and strengths does Breyna come in?

Accepted Answer

Breyna is supplied as a pressurized metered-dose inhaler (MDI) for oral inhalation. The medication is contained within a canister that is used with a specific actuator provided by the manufacturer.

Device Features

The inhaler includes a built-in dose counter to help track the number of inhalations remaining in the canister.

The device is designed to deliver a combination of a corticosteroid and a long-acting beta2-adrenergic agonist directly to the lungs.

Question 10

What is the FDA approval status of Breyna?

Accepted Answer

FDA Approval and Indications

Breyna is an FDA-approved inhalation aerosol containing budesonide and formoterol fumarate dihydrate. It is approved for the following conditions:

Asthma: For patients 6 years of age and older whose condition is not well-controlled on a long-term asthma-control medication or whose disease severity requires two types of maintenance treatment.

COPD: For the maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

Regulatory Requirements

The FDA does not currently require a Risk Evaluation and Mitigation Strategy (REMS) for this medication. It is important to note that Breyna is approved for maintenance treatment and is not indicated for the treatment of acute asthma attacks or sudden worsening of COPD symptoms.

Breyna was approved as the first generic version of Symbicort, meeting the same rigorous standards for quality, safety, and effectiveness as the brand-name product.

Question 11

What should I know about Breyna and cost?

Accepted Answer

Generic Availability

As a generic medication, Breyna contains the same active ingredients (budesonide and formoterol fumarate dihydrate) as the brand-name drug Symbicort. Generic drugs are generally available at a lower cost than their brand-name counterparts because the manufacturers do not have to repeat the initial clinical trials required for a new drug approval.

Factors Affecting Cost

The out-of-pocket cost for Breyna can vary based on several factors:

Insurance Coverage: Most health insurance plans, including Medicare Part D and Medicaid, cover generic medications. Breyna may be placed on a lower cost-sharing tier than brand-name inhalers, which can reduce the patient's copayment.

Pharmacy Choice: Prices may differ between retail pharmacies, and some may offer lower prices through mail-order programs or preferred network status.

Dosage and Quantity: The total cost will depend on the strength of the inhaler prescribed and the number of units purchased at one time.

Financial Assistance

Patients who are uninsured or underinsured may be eligible for savings programs or patient assistance initiatives. Some manufacturers offer coupons or discount cards that can be used at the pharmacy to reduce the cost of the prescription. It is advisable to consult with a pharmacist or insurance provider to determine the most accurate pricing and available savings options.

Breyna

Medication Quick Facts

📋Overview

What It's Used For

How It Works

Side Effects

Warnings & Precautions

Dosage & How to Take

Pregnancy & Breastfeeding

Forms & Strengths

FDA / Regulatory Status

Price Information

FAQ

Found an Error?